News Conference News VIVA 2025 ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss L.A. McKeown November 07, 2025
News Conference News ESC 2025 MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide Caitlin E. Cox August 30, 2025
News Daily News PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes Todd Neale July 14, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2025 Caitlin E. Cox April 30, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News TCT 2024 Bleeding After MCS in DanGer Shock: When, Where, and What to Do? Caitlin E. Cox October 31, 2024
News Daily News SCAI Releases Practical, Technical Advice for Primary PCI in STEMI Michael O'Riordan October 10, 2024
News Conference News HFSA 2024 ‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM L.A. McKeown October 02, 2024
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Daily News Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear Caitlin E. Cox July 03, 2024
News Conference News ESC Heart Failure 2024 SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM Michael O'Riordan May 13, 2024
News Features After DanGer Shock’s Win in AMICS for Impella: What’s Next? Caitlin E. Cox May 02, 2024
News Conference News EHRA 2024 Ultralow-Temperature Cryoablation Promising for Monomorphic VT Todd Neale April 12, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Daily News New Risk Score Better for Capturing Medical Urgency for Heart Transplantation Michael O'Riordan February 19, 2024
News Daily News Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients L.A. McKeown January 02, 2024